0001782348-26-000001.txt : 20260130
0001782348-26-000001.hdr.sgml : 20260130
20260130134636
ACCESSION NUMBER: 0001782348-26-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260130
DATE AS OF CHANGE: 20260130
EFFECTIVENESS DATE: 20260130
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alume Biosciences Inc
CENTRAL INDEX KEY: 0001782348
ORGANIZATION NAME:
EIN: 822094372
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-562705
FILM NUMBER: 26582064
BUSINESS ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 205
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-254-7116
MAIL ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 205
CITY: LA JOLLA
STATE: CA
ZIP: 92037
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001782348
Alume Biosciences Inc
2223 AVENIDA DE LA PLAYA
SUITE 205
LA JOLLA
CA
CALIFORNIA
92037
858-254-7116
DELAWARE
None
None
Corporation
true
Quyen
Nguyen
2223 Avenida de La Playa
Suite 205
La Jolla
CA
CALIFORNIA
92037
Executive Officer
Director
Brett
Berman
2223 Avenida de La Playa
Suite 205
La Jolla
CA
CALIFORNIA
92037
Executive Officer
Director
Dan
Bradbury
2223 Avenida de La Playa
Suite 205
La Jolla
CA
CALIFORNIA
92037
Director
Kim
Kamdar
2223 Avenida de La Playa
Suite 205
La Jolla
CA
CALIFORNIA
92037
Director
Magda
Marquet
2223 Avenida de La Playa
Suite 205
La Jolla
CA
CALIFORNIA
92037
Director
Jean-Pierre
Millon
2223 Avenida de La Playa
Suite 205
La Jolla
CA
CALIFORNIA
92037
Director
James
Schmidt
2223 Avenida de La Playa
Suite 205
La Jolla
CA
CALIFORNIA
92037
Executive Officer
Kaveri
Parker
2223 Avenida de La Playa
Suite 205
La Jolla
CA
CALIFORNIA
92037
Executive Officer
Biotechnology
Decline to Disclose
- 06b
true
0001782348-25-000005
2025-10-30
false
true
false
25000
PHX Financial Inc.
144403
None
None
100 Wall Street
10th Floor
New York
NY
NEW YORK
10005
AL
ALABAMA
AZ
ARIZONA
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
FL
FLORIDA
GA
GEORGIA
HI
HAWAII
IL
ILLINOIS
MA
MASSACHUSETTS
MI
MICHIGAN
MN
MINNESOTA
MS
MISSISSIPPI
MO
MISSOURI
NV
NEVADA
NH
NEW HAMPSHIRE
NJ
NEW JERSEY
NY
NEW YORK
NC
NORTH CAROLINA
OH
OHIO
OR
OREGON
PA
PENNSYLVANIA
TN
TENNESSEE
TX
TEXAS
UT
UTAH
VA
VIRGINIA
WA
WASHINGTON
false
23499998
5967305
17532693
false
77
547601
true
0
The stated commission amount consists of commissions of approximately 77% of such amount and reimbursement of expenses of approximately 23% of such amount.
0
false
Alume Biosciences Inc
James Schmidt
James Schmidt
Chief Financial Officer
2026-01-29